埃菲德拉西尼卡的物质基础和机制干扰风冷的寒冷
Yuanyuan Wu1, Mengnan Zeng1, Bing Cao1
1School of Pharmacy, Henan University of Chinese Medicine, 156 Jinshui East Road, Zhengzhou 450046, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province, 156 Jinshui East Road, Zhengzhou 450046, China.
International immunopharmacology
|March 9, 2025
概括
来自Ephedra sinica的类提取物通过调节免疫反应和氧化应激,有效地治疗老鼠的风寒感冒症状. 和伪是关键成分,通过TRPM8/TLR4-NFκB通路和CHRM3.3起作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传统中国医药 传统中国医药
- 免疫学 免疫学 免疫学
背景情况:
- (Ephedra sinica) (MH) 在治疗风冷感冒方面有着悠久的历史.
- 埃菲德拉西尼卡的物质基础和作用机制仍未得到充分研究.
- 了解这些方面对于验证其传统用途和开发现代治疗方法至关重要.
研究的目的:
- 为了研究Ephedra sinica在治疗风冷感冒时的药学动力学物质基础.
- 为了阐明Ephedra sinica提取物的潜在作用机制.
- 确定关键的活性成分和参与其治疗作用的信号通路.
主要方法:
- 风冷的动物模型是使用暴露在寒冷和风中的老鼠建立的.
- 施用了不同种类的Ephedra sinica (类,非类,多糖类) 提取物.
- 使用BEAS-2B细胞的体外细胞模型被用于研究乙和伪乙的作用.
主要成果:
- 类提取物 (SWJ) 在体温和感冒相关症状方面表现出最显著的改善.
- SWJ治疗减弱了氧化应激,调节了免疫细胞活性,并降低了炎症标志物 (IL-4,IgE,TRPM8,TLR4,P-P65/P65) 的调节.
- 和伪被确定为潜在的关键成分,影响TRPM8/TLR4-NFκB通路和CHRM3.
结论:
- 化物提取物Ephedra sinica是其对抗风冷寒的有效性的主要材料基础.
- 治疗效果通过TRPM8/TLR4-NFκB通路和CHRM3.3的调节进行调节.
- 和伪在观察到的药理作用中起着重要作用.
相关概念视频
01:28Adrenergic Agonists: Mixed-Action Agents
649
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
649
01:24Antiasthma Drugs: Methylxanthines
166
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
166
01:26Thermoregulation
859
The human body has a sophisticated thermoregulation system that employs negative feedback mechanisms to maintain an optimal core temperature. When the core temperature drops, peripheral and central thermoreceptors send signals to the hypothalamus, activating the heat-promoting center. This center triggers several responses aimed at increasing the core temperature. First, vasoconstriction reduces the flow of warm blood from internal organs to the skin so that the heat is not lost from the skin,...
859
02:45Responses to Heat and Cold Stress
13.3K
Every organism has an optimum temperature range within which healthy growth and physiological functioning can occur. At the ends of this range, there will be a minimum and maximum temperature that interrupt biological processes.
13.3K
01:29Decreased Body Temperature
599
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
599
01:28Cholinergic Antagonists: Pharmacological Actions
751
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
751